Navigation Links
Trialing New Medical Products Gets Faster and More Secure

LONGMONT, Colo., Dec. 13, 2011 /PRNewswire/ -- Data security and accuracy is vital to all industries, particularly in the health field. The process by which a pharmaceutical company compiles and analyzes information from clinical trials can significantly affect the timing and viability of a new product. nSpire Health is changing this process by providing its domestic and international pharmaceutical customers with faster, more accurate, and more reliable information.


nSpire Health, a company which develops and manufactures respiratory care tools and services, has selected AT&T* to provide wireless connectivity for an nSpire Health mobile data services application that collects and analyzes information from patients and delivers it directly to pharmaceutical companies trialing a new product. nSpire Health utilizes a wireless device and AT&T's Enterprise On-Demand platform – a custom web portal that helps control and manage wireless device inventory –  to capture data measuring a patient's intake of and response to new respiratory products. This data is then sent to nSpire Health's customers – pharmaceutical companies. The companies can use this information to evaluate the new product and help them support their case in advancing a new drug through the FDA's approval processes.

Benefits to nSpire Health
As the healthcare industry moves toward electronic files for patients and companies, nSpire Health recognized increasing competition not only in price points, but also in accuracy and security of information.

  • Previously, nSpire Health had no single way of monitoring usage of its wireless device. Patients would take an nSpire Health device home for the purpose of trialing new medical products, but would then often misuse it. With AT&T EOD service, nSpire Health can monitor usage, restrict or disable certain features, as well as deliver the data compiled from patients.
  • This capability allows nSpire Health to conduct medical monitoring, with proper controls, at a managed cost.
  • With AT&T's wireless network and EOD platform, nSpire Health is better positioned to provide its customers data integrity and offer a more efficient solution for capturing and transmitting that information.

"Patient trials of new drugs are a very important part of research and development processes for international pharmaceutical companies, as this helps them to create and market new drugs," said Chip Owen, Global Director of Clinical Trial Information Services for nSpire Health. "We knew we needed a cost-effective solution that moved as quickly as our customers do and maintained a high level of data accuracy and security – AT&T answered our call for flexibility in machine-to-machine services."

To view how nSpire Health is utilizing AT&T's EOD platform, check out this video:

*AT&T products and services are provided or offered by subsidiaries and affiliates of AT&T Inc. under the AT&T brand and not by AT&T Inc.

About nSpire Health
nSpire Health develops and manufactures respiratory care products and provides related services. The company is focused on cardiopulmonary diagnostics, respiratory clinical trial services, and disease management solutions designed to improve health care productivity while increasing the overall quality of patient care. nSpire Health is the exclusive provider of PiKo® home health monitors, PiKoLogic™ ePRO solutions, and HDpft™ systems, the most accurate and precise pulmonary function testing systems worldwide.  For further information contact or visit

About AT&T
AT&T Inc. (NYSE: T) is a premier communications holding company and one of the most honored companies in the world. Its subsidiaries and affiliates – AT&T operating companies – are the providers of AT&T services in the United States and around the world. With a powerful array of network resources that includes the nation's fastest mobile broadband network, AT&T is a leading provider of wireless, Wi-Fi, high speed Internet, voice and cloud-based services. A leader in mobile broadband and emerging 4G capabilities, AT&T also offers the best wireless coverage worldwide of any U.S. carrier, offering the most wireless phones that work in the most countries. It also offers advanced TV services under the AT&T U-verse® and AT&T |DIRECTV brands. The company's suite of IP-based business communications services is one of the most advanced in the world. In domestic markets, AT&T Advertising Solutions and AT&T Interactive are known for their leadership in local search and advertising. 

Additional information about AT&T Inc. and the products and services provided by AT&T subsidiaries and affiliates is available at This AT&T news release and other announcements are available at and as part of an RSS feed at Or follow our news on Twitter at @ATT.

© 2011 AT&T Intellectual Property. All rights reserved. Mobile broadband not available in all areas. AT&T, the AT&T logo and all other marks contained herein are trademarks of AT&T Intellectual Property and/or AT&T affiliated companies. All other marks contained herein are the property of their respective owners.


Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nonin Medical GO2™ Finger Pulse Oximeter to be Featured on "The Balancing Act" TV Show on Lifetime Television
2. The Huntington Medical Foundation -- Pasadenas Premier Medical Group
3. American Association for Homecare Urges Congress to Enact Market-Based Alternative to Medicares Bidding Program for Home Medical Equipment
4. Nonin Medical Announces the European Launch of EQUANOX Advance™ Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference
5. Regenerative Medicine Company BioParadox adds Healthcare and Medical Device Expert, Michael Kleine, to its Board of Directors
6. Medical Alarm Concepts™ Announces Roll-Out of the Second Phase of the MediPendant™ Marketing Campaign at Albertsons LLC Grocery Stores
7. Global Medical Ultrasound Equipment Industry
8. Flagstaff Medical Center to Use Smart Phones to Extend Care for Heart Patients
9. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
10. Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology
11. NHS National Innovation Centre Estimates Sequana Medicals ALFApump® System Could Save the NHS £50 Million in ascites Care Annually
Post Your Comments:
(Date:11/24/2015)... Nueva York , 24 de noviembre ... fabricante del Avery Breathing Pacemaker System, se complace ... MD; Ph.D. como consultor clínico. ... --> Foto -   ... doctor Jonzon es un fisiólogo y consultor en ...
(Date:11/24/2015)... 24, 2015 Avery Biomedical Devices (ABD), manufacturer ... announce the appointment of Anders Jonzon , MD; ... Dr. Jonzon is a Physiologist ... Hospital, Uppsala University, Uppsala and Children,s Hospital, Karolinska, ... a fellow at the Cardiovascular Institute (UCSF). His research ...
(Date:11/24/2015)... November 24, 2015 F1000Workspace - ... - since it was launched just six months ago. ... and authoring platform for scientists - since it was launched ... have been loaded on to F1000Workspace - a ... since it was launched just six months ago. ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a noted general ... of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in many ... the doctor uses other traditional cutting tools, such as the scalpel and high-speed drill, ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article published November 12th ... which patients are or are not eligible for bariatric surgery. The article explains that ... are more than 100 pounds overweight, or have a BMI of 35 and over ...
(Date:11/24/2015)... ... 2015 , ... It takes only three to five seconds to make a ... first impression be positive and reflects business values. If a client starts with a ... to return. They will also share their thoughts about a business with others, which ...
(Date:11/24/2015)... ... 2015 , ... Cancer patients, survivors, caregivers, family members and ... taping of the next CURE Connections® video series on Saturday, Dec. ... at Georgetown University Hotel & Conference Center in Washington, D.C. , CURE Connections, ...
(Date:11/24/2015)... Danbury, CT (PRWEB) , ... November 24, 2015 , ... ... Network (WCHN) today announced an innovative study designed to yield insights into how to ... potential development of biomarkers for pancreatic cancer from small, non-coding RNA molecules (ncRNA), genetic ...
Breaking Medicine News(10 mins):